COSMO Pharmaceuticals (Switzerland) Today
| COPN Stock | CHF 63.20 0.40 0.64% |
Performance0 of 100
| Odds Of DistressLess than 9
|
COSMO Pharmaceuticals is selling for under 63.20 as of the 26th of November 2024; that is 0.64% up since the beginning of the trading day. The stock's lowest day price was 62.0. COSMO Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for COSMO Pharmaceuticals SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland. COSMO PHARM operates under Drug Manufacturers - Major classification in Switzerland and is traded on Switzerland Exchange. The company has 16.38 M outstanding shares. More on COSMO Pharmaceuticals SA
Moving against COSMO Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
COSMO Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. COSMO Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding COSMO Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
COSMO Pharmaceuticals SA (COPN) is traded on SIX Swiss Exchange in Switzerland and employs 292 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate COSMO Pharmaceuticals's market, we take the total number of its shares issued and multiply it by COSMO Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. COSMO Pharmaceuticals operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 16.38 M outstanding shares.
COSMO Pharmaceuticals SA has accumulated about 217.97 M in cash with 12.61 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.53.
Check COSMO Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationCOSMO Pharmaceuticals holds a total of 16.38 Million outstanding shares. COSMO Pharmaceuticals SA retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check COSMO Ownership Details
COSMO Pharmaceuticals Risk Profiles
Although COSMO Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate COSMO Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.7618 | |||
| Standard Deviation | 0.9696 | |||
| Variance | 0.9402 | |||
| Risk Adjusted Performance | (0.28) |
COSMO Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in COSMO Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
COSMO Pharmaceuticals Corporate Management
Elected by the shareholders, the COSMO Pharmaceuticals' board of directors comprises two types of representatives: COSMO Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of COSMO. The board's role is to monitor COSMO Pharmaceuticals' management team and ensure that shareholders' interests are well served. COSMO Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, COSMO Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Niall Donnelly | Chief Officer | Profile | |
| Biagio Vigano | Chief Officer | Profile | |
| Davide Malavasi | Qualified Director | Profile | |
| Marco Lecchi | Chief Officer | Profile | |
| Luigi Longo | Chief Officer | Profile | |
| Hazel Winchester | Head Relations | Profile | |
| Giulio Evangelisti | AI Production | Profile |
Additional Tools for COSMO Stock Analysis
When running COSMO Pharmaceuticals' price analysis, check to measure COSMO Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSMO Pharmaceuticals is operating at the current time. Most of COSMO Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of COSMO Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSMO Pharmaceuticals' price. Additionally, you may evaluate how the addition of COSMO Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.